VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
EPS (Diluted)
VIVA Biotech Holdings
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
VIVA Biotech Holdings
HKEX:1873
|
EPS (Diluted)
¥0
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
EPS (Diluted)
¥3
|
CAGR 3-Years
31%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
EPS (Diluted)
¥0
|
CAGR 3-Years
25%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-5%
|
CAGR 5-Years
23%
|
CAGR 10-Years
29%
|
|
Genscript Biotech Corp
HKEX:1548
|
EPS (Diluted)
$0
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's EPS (Diluted)?
EPS (Diluted)
-0.1
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's EPS (Diluted) amounts to -0.1 CNY.
What is VIVA Biotech Holdings's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
38%
Over the last year, the EPS (Diluted) growth was 79%. The average annual EPS (Diluted) growth rates for VIVA Biotech Holdings have been 38% over the past three years .